Abstract
Borrelia burgdorferi is the causative agent of Lyme disease that persists in a complex enzootic life cycle, involving Ixodes ticks and vertebrate hosts. The microbe invades ticks and vertebrate hosts in spite of active immune surveillance and potent microbicidal responses, and establishes long-term infection utilising mechanisms that are yet to be unravelled. The pathogen can cause multi-system disorders when transmitted to susceptible mammalian hosts, including in humans. In the past decades, several studies identified a limited number of B. burgdorferi gene-products critical for pathogen persistence, transmission between the vectors and the host, and host–pathogen interactions. This review will focus on the interactions between B. burgdorferi proteins, as well as between microbial proteins and host components, protein and non-protein components, highlighting their roles in pathogen persistence in the mammalian host. A better understanding of the contributions of protein interactions in the microbial virulence and persistence of B. burgdorferi would support development of novel therapeutics against the infection.
Keywords: Borrelia burgdorferi, host persistence, Lyme disease, microbial infectivity, protein interactions
1 ∣. INTRODUCTION
Borrelia burgdorferi, the causative agent of Lyme disease, persists through a complex enzootic infection cycle between the tick Ixodes family, in particular Ixodes scapularis, and vertebrate animals (Radolf, Caimano, Stevenson, & Hu, 2012). Lyme disease is highly prevalent in the United States, Europe, and parts of Asia, although the rate of the disease is globally underestimated (Mead, 2015). Currently, a human vaccine against Lyme disease is unavailable; therefore the development of an effective prevention against the infection remains a warranted research goal. Once transmitted, the pathogen B. burgdorferi invades host tissues, whether in ticks or vertebrates, and it interacts with host molecules in order to establish infection (Radolf et al., 2012; Steere, Coburn, & Glickstein, 2004; Thakur et al., 2017). Because protein–protein interactions are highly specific and dynamic, events that can regulate critical cellular structure and/ or physiological events (Blundell et al., 2000), such biomolecular interactions, may modulate B. burgdorferi infectivity. A variety of molecular tools are now available to study dynamic spirochete proteome (Norris, 2006; Yang et al., 2011) as well as protein–protein interactions in B. burgdorferi (Yang et al., 2018). These interactions are highly dynamic events that are likely to contribute unique surface structure of B. burgdorferi. Since protein–protein interactions may be particularly amenable as therapeutic targets, further studies are highly warranted to explore these novel areas of spirochete research. Herein, we broadly discuss protein–protein interactions within spirochete cells and ones involving vertebrate host ligands that impact some of the key physiological process in the microbe and in the host, such as localisation of outer membrane protein, cell division, chemotaxis, attachment to host cell or extracellular matrix molecules, and complement resistance. Due to space limitations, we are unable to discuss all relevant publications, rather we highlight a limited set of representative studies to exemplify how protein interactions support B. burgdorferi infectivity and persistence.
2 ∣. PROTEIN INTERACTIONS INVOLVING SPIROCHETE PROTEINS
B. burgdorferi differentially produces specific proteins as the pathogen infects a host or cycles between arthropods and vertebrate hosts (de Silva & Fikrig, 1997). At the spirochete surface, an outer membrane (OM) has an atypical organisation amongst Gram-negative bacteria (Bergström & Zückert, 2010). Unlike Gram-negative bacteria, the spirochete OM lacks the classical lipopolysaccharides, instead it harbours numerous lipoproteins (Rosa, Tilly, & Stewart, 2005). These lipoproteins form distinct membrane protein complexes. Many of these protein complexes contain common or ubiquitous members, such as outer surface proteins like OspA, –B, –C, –D, and Lp6.6 (Yang et al., 2011). In contrast, other proteins, namely, P66 (Coburn, Leong, & Chaconas, 2013) and BB0405 (Kung et al., 2016), are constituents of specific functional complexes (Yang et al., 2011). Some of these functional complexes are involved in biomolecular interactions, including flagellar proteins that are likely crucial for the stability and the assembly of flagellar structure and motor, such as FlgE (Sal et al., 2008). Others, like the ones we highlight below, support microbial physiology and infectivity.
2.1 ∣. BB0323 complex
The gene product BB0323 is part of an OM protein complex that is essential for cell fission (Stewart, Hoff, Fischer, Krum, & Rosa, 2004; Zhang, Yang, Kumar, & Pal, 2009). BB0323 is the substrate of at least two specific proteases in B. burgdorferi—a periplasmic serine protease called B. burgdorferi high temperature requirement protease A (HtrA) or BbHtrA (BB0104) and a C-terminal protease A, named as CtpA (Kariu, Yang, Marks, Zhang, & Pal, 2013; Ostberg et al., 2004; Ye et al., 2016). These proteases produce two discrete polypeptides with approximate MW around 27 and 12 kDa that encompass the N-terminal and C-terminal regions of BB0323, respectively. These polypeptides also form a homomeric complex (Kariu et al., 2013) while N-terminal polypeptide also interact with another spirochete protein, BB0238 (Groshong et al., 2014; Kariu et al., 2015; Thakur et al., 2017). The association of BB0323 and BB0238 proteins contributes to their mutual posttranslational stability (Kariu et al., 2015). More recently, it was shown that the interaction between BB0323 and a stretch of 11 amino acid residues of BB0238 may be essential in the successful establishment of spirochete infection and transmission to mammals (Thakur et al., 2017). The biologically relevant interaction between BB0323 and BB0238 supports the notion that spirochete protein–protein interactions are essential for vertebrate host infection, therefore constitute a viable target for future therapeutic interventions, for example, next-generation drug targets (Khan, Ahmad, Ahmad, Flynn, & Kumar, 2011; Lin et al., 2012) to thwart Lyme borreliosis.
2.2 ∣. BB0795 complex
This heterooligomeric OM protein complex known as a β-barrel assembly machine, or BAM, has also been recently discovered in B. burgdorferi (Lenhart & Akins, 2009). Like other Gram-negative bacteria, a functional BAM complex is required for proper assembly of proteins into the spirochete OM. At least three proteins, BB0795, BB0324, and BB0028, were characterised as an integral structural and functional part of the complex (Lenhart, Kenedy, Yang, Pal, & Akins, 2012). A model for the spirochete BAM complex has been proposed, with BB0795, BB0324, and BB0028 being orthologs to BamA, BamB, and BamD, respectively, in Gram-negative bacteria (Kenedy, Lenhart, & Akins, 2012; Lenhart et al., 2012). The BAM complex plays an essential role in spirochete growth and infection, hence making its subunit interactions, such as BamA:BamB or BamA:BamD potential targets for novel inhibitors. More recently, Iqbal, Kenedy, Lybecker, and Akins (2016) have identified the inner membrane protein TamB, a constituent of the translocation and assembly module, as another subunit of the BAM complex (Iqbal et al., 2016). Thereby it indicates that the two complexes crosstalk and play an important role in OM biogenesis and supporting microbial infectivity.
3.∣. PROTEIN INTERACTIONS INVOLVING HOST LIGANDS
B. burgdorferi persists in an enzootic cycle where interactions of spirochete proteins with either host or vector proteins play a critical role in infectivity. We discussed interactions involving tick molecules in several of our past reviews (de Silva, Tyson, & Pal, 2009, Kung, Anguita, & Pal, 2013, Pal & Fikrig, 2003, Pal & Fikrig, 2010), so this section will essentially focus on interactions of spirochete proteins with mammalian ligands, as exemplified below:
3.1 ∣. Extracellular matrix binding proteins
As soon as B. burgdorferi are deposited into the host dermis, spirochetes must move across the extracellular matrix (ECM) to reach blood vessels and disseminate to distant targeted organs, a process that is likely to rely on protein interactions. B. burgdorferi encodes a number of surface proteins that mediate spirochete dissemination and persistence through interactions with host ECM molecules (Coburn et al., 2013; Coburn, Fischer, & Leong, 2005). The most widely studied examples involve (a) interaction between spirochete decorin binding protein (DBP) A and B with host glycosaminoglycans containing ligands like decorin (Blevins, Hagman, & Norgard, 2008; Brown et al., 2001; Caimano, Eggers, Hazlett, & Radolf, 2004; Guo, Brown, Dorward, Rosenberg, & Hook, 1998; Hyde et al., 2011; Lin et al., 2014; Shi, Xu, McShan, & Liang, 2008; Weening et al., 2008), (b) binding of multiple B. burgdorferi proteins, such as BBK32, RevA/RevB, and BB0347, with host fibronectin (Brissette & Gaultney, 2014, Gaultney, Gonzalez, Floden, & Brissette, 2013, Hyde et al., 2011), (c) interaction of putative lipoproteins BBA33 and CRASP-1 with host collagens, especially with type-I/III and IV (Hallstrom et al., 2010; Zhi et al., 2015), (d) binding of ErpX and BmpA with host laminin (Brissette, Verma, Bowman, Cooley, & Stevenson, 2009; Verma, Brissette, Bowman, & Stevenson, 2009), (e) interaction of BbHtrA with several ECM molecules and most notably aggrecan, a major proteoglycan in joints (Russell & Johnson, 2013), and (f) binding of B. burgdorferi enolase, Erp proteins, OspA, OspC, and BBA70 with plasmin (ogen; Floden, Watt, & Brissette, 2011; Fuchs, Wallich, Simon, & Kramer, 1994; Hallstrom et al., 2010; Koenigs et al., 2013; Lagal, Portnoi, Faure, Postic, & Baranton, 2006; Nogueira, Smith, Qin, & Pal, 2012; Onder et al., 2012; Toledo, Coleman, Kuhlow, Crowley, & Benach, 2011), a host protease able to degrade a variety of ECM components (Coleman, Roemer, & Benach, 1999) such as fibronectin, laminin, and vitronectin. Overall, a large number of spirochete surface proteins interact with a large array of ECM ligands to promote B. burgdorferi dissemination and colonisation while influencing host responses and ensuring microbial persistence in diverse mammalian tissues.
3.2 ∣. Integrin binding proteins
B. burgdorferi can colonise multiple distant host tissues establishing long-term persistence in disseminated organs. Spirochete encodes specific proteins such as P66, BBB07, and BB0172 that can assist microbial colonisation via interaction with host ligands like specific integrin classes, a transmembrane receptor that facilitates adhesion to the ECM (Behera et al., 2008; Ristow et al., 2012; Ristow et al., 2015; Wood, Tamborero, Mingarro, & Esteve-Gassent, 2013). Amongst these interactions, for example, one between BBB07 and a host integrin α3β1 integrin leads to the modulation of proinflammatory mediators in chondrocytes (Behera et al., 2008). Another spirochete ligand BB0172 has also been shown to interact with the same α3β1 integrin in a metal ion-dependent manner (Wood et al., 2013). Therefore, interactions between a subset of integrin molecules and specific spirochete ligands may promote B. burgdorferi infection in multiple tissues, as well as triggering cellular proinflammatory responses in the host.
3.3 ∣. Chemotaxis proteins
The transmission of spirochete requires its migration from the tick to the host dermis and then dissemination within the host from one organ to the other. Chemotaxis plays critical roles in supporting B. burgdorferi persistence in the enzootic infection cycle and this is partially mediated through chemotaxis (Che) proteins (Charon et al., 2012, Charon & Goldstein, 2002, Li, Motaleb, Sal, Goldstein, & Charon, 2000, Motaleb, Liu, & Wooten, 2015, Motaleb, Miller, Bakker, Li, & Charon, 2007, Sze, Zhang, Kariu, Pal, & Li, 2012). The chemotaxis signalling complex (Charon et al., 2012; Goldstein et al., 2010) is composed of three major components: methyl-accepting chemotaxis proteins (MCPs), the histidine kinase CheA, and the response regulator CheY. MCPs sense environmental and intracellular signals and control the activity of CheA after being coupled to it by CheW. Activated CheA then phosphorylates CheY, which interacts with the motor switch complex to regulate the flagella rotation. The B. burgdorferi chemotaxis pathway harbours multiple homologues of the coupling protein CheW (CheW1/bb0312, CheW2/bb0565, CheW3/bb0670), histidine kinase CheA (CheA1/bb0567, CheA2/bb0569), and the response regulator CheY (CheY1/bb0551, CheY2/bb0570, CheY3/ bb0672). The interaction of CheW1 and CheW3 with CheA2, or CheW2 with CheA1, suggest the presence of two chemosensory pathways that could participate in different stages of the tick–mammalian cycle of the pathogen. Autophosphorylated histidine kinase CheA transfers the phosphate group to CheY, which in turn gets dephosphorylated by CheX/bb0671 phosphatase (Djordjevic & Stock, 1998). The phosphatase activity of CheX is enhanced upon binding with CheD/bb0606. In addition to binding with CheX, CheD also interacts with two of the six methyl-accepting chemotaxis protein receptor (MCPs), indicating that CheD may also regulate the receptor activity (Moon, Hobbs, & Motaleb, 2016). In addition, CheY3 is shown to be phosphorylated by CheA2 and is a key regulator of spirochete movement (Motaleb et al., 2015; Novak et al., 2016).
3.4 ∣. Complement binding proteins
The mammalian complement system represents an early and effective innate immune defence against invading pathogens like B. burgdorferi. But the spirochete is capable of counteracting the complement's response by producing several complement regulator-acquiring surface proteins (CRASPs) able to inhibit the complement system notably through the direct binding of the host complement regulatory/inhibitory molecules like factor H, the C7, or the C9 component (Caine & Coburn, 2016, de Taeye, Kreuk, van Dam, Hovius, & Schuijt, 2013, Kraiczy, 2016). Spirochete proteins capable of binding and thwarting the complement's action include CRASP1-5, CspA/Z, Erp Proteins, and OspE-related proteins. Besides, BBK32 has been shown to block the activation of the C1 complement complex (Garcia, Zhi, Wager, Hook, & Skare, 2016). Early in the process of dissemination and while interacting with the ECM, the interaction between spirochete protein BBA70 with plasminogen inhibits the host innate immune response through the degradation of complement proteins C3b and C5. OspC has also been shown to inhibit the classical and the lectin complement pathway by interacting with the C4b protein (Caine et al., 2017), The redundancy of these proteins allows B. burgdorferi to target and evade various steps of complement signal cascade, including its regulatory pathways ensuring microbial survival in the host (Koenigs et al., 2013).
3.5 ∣. Interaction with other host proteins
B. burgdorferi encodes additional proteins that assist in microbial evasion of host immunity. For example, one of the B. burgdorferi surface proteins, annotated as Lmp1, is involved in various functions in spirochete infectivity, including host–pathogen interactions and evasion of host adaptive immunity by spirochetes (Antonara, Chafel, LaFrance, & Coburn, 2007; Yang et al., 2010; Yang et al., 2016; Yang, Coleman, Anguita, & Pal, 2009). More recently, the middle region of Lmp1 was shown to interact with host chondroitin-6-sulfate, which facilitates infection of mammalian hosts (Yang et al., 2016). Another prominent example is the spirochete surface protein, OspC, which binds a tick salivary gland protein, Salp15 (Anguita et al., 2002; Ramamoorthi et al., 2005); this complex then modulates the host immune response during the establishment of infection in mammals as the pathogen is transmitted from an infected tick. The OspC or Flagellin proteins are also known to interact with specific Toll like receptors in the host, specifically TLR2 or TLR5, respectively, again influencing the host immune response and modulating the expression of immune effectors, such as matrix metalloproteases (MMP) 9 (Gebbia, Coleman, & Benach, 2004). Once B. burgdorferi induces MMPs in host cells, these events might further assist the dissemination of the pathogen by remodelling the ECM (Behera et al., 2004; Behera, Hildebrand, Scagliotti, Steere, & Hu, 2005; Schramm et al., 2012). In addition, B. burgdorferi also encodes an elaborate antigenic variation system, via production of a surface protein VlsE, which interfaces with host adaptive immune response to ultimately help the spirochete to evade microbicidal responses (Zhang, Hardham, Barbour, & Norris, 1997); this interaction directly influences population dynamics and persistence of B. burgdorferi in the mammalian host and the tick (Brisson, Drecktrah, Eggers, & Samuels, 2012; Norris, 2014; Rogovskyy et al., 2015).
4 ∣. CONCLUDING REMARKS
B. burgdorferi is a successful multi-host pathogen that developed elaborate defence strategies to combat host microbicidal responses so it can establish long-term infection in diverse array of tissues. As we demonstrated in this review, protein interactions play a critical role in microbial infectivity, pathogen entry, dissemination, and colonisation of various host or vector tissue milieus (Figure 1). Spirochetes demonstrate unique and highly specific interactions involving conserved spirochete proteins that are essential for infectivity in the vertebrate host. When interacting with host proteins, spirochetes use some redundancy, i.e. one involving the same host protein with multiple spirochete proteins or one between a specific spirochete protein and ubiquitous host ligands highlighting the importance of these biological events that ultimately facilitate microbial infectivity. Although these molecular interactions are likely to be complex, transient, and dynamic, they nevertheless represent novel molecular targets for therapeutics to control B. burgdorferi infection.
ACKNOWLEDGEMENTS
We are thankful to Gaelle Kolb for the critical reading of the manuscript. We also thank members of our laboratory for their assistance with the study. This work is supported by funding from the National Institute of Allergy and Infectious Diseases (Award Number AI080615 and AI116620 to U.P.). The authors declare that they have no competing financial interests.
REFERENCES
- Anguita J, Ramamoorthi N, Das S, Conze D, Askenase P, Rincón M, … Fikrig E (2002). Salp15, an Ixodes scapularis saliva protein, inhibits CD4+ T cell activation. Immunity, 16, 849–859. [DOI] [PubMed] [Google Scholar]
- Antonara S, Chafel RM, LaFrance M, & Coburn J (2007). Borrelia burgdorferi adhesins identified using in vivo phage display. Molecular Microbiology, 66, 262–276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Behera AK, Durand E, Cugini C, Antonara S, Bourassa L, Hildebrand E, et al. (2008). Borrelia burgdorferi BBB07 interaction with integrin alpha3beta1 stimulates production of proinflammatory mediators in primary human chondrocytes. Cellular Microbiology, 10, 320–331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Behera AK, Hildebrand E, Scagliotti J, Steere AC, & Hu LT (2005). Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis. Infection and Immunity, 73, 126–134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Behera AK, Thorpe CM, Kidder JM, Smith W, Hildebrand E, & Hu LT (2004). Borrelia burgdorferi-induced expression of matrix metalloproteinases from human chondrocytes requires mitogen-activated protein kinase and Janus kinase/signal transducer and activator of transcription signaling pathways. Infection and Immunity, 72, 2864–2871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bergström S, & Zückert WR (2010). Structure, function and biogenesis of the Borrelia cell envelope. In Samuels DS, & Radolf JD (Eds.), Borrelia, molecular biology, host interaction and pathogenesis (pp. 139–166). Norfolk, UK: Caister Academic Press. [Google Scholar]
- Blevins JS, Hagman KE, & Norgard MV (2008). Assessment of decorin-binding protein A to the infectivity of Borrelia burgdorferi in the murine models of needle and tick infection. BMC Microbiology, 8, 82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blundell TL, Burke DF, Chirgadze D, Dhanaraj V, Hyvonen M, Innis CA, et al. (2000). Protein-protein interactions in receptor activation and intracellular signalling. Biological Chemistry, 381, 955–959. [DOI] [PubMed] [Google Scholar]
- Brissette CA, & Gaultney RA (2014). That's my story, and I'm sticking to it—An update on B. burgdorferi adhesins. Frontiers in Cellular and Infection Microbiology, 4, 41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brissette CA, Verma A, Bowman A, Cooley AE, & Stevenson B (2009). The Borrelia burgdorferi outer-surface protein ErpX binds mammalian laminin. Microbiology, 155, 863–872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brisson D, Drecktrah D, Eggers CH, & Samuels DS (2012). Genetics of Borrelia burgdorferi. Annual Review of Genetics, 46, 515–536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown EL, Wooten RM, Johnson BJ, Iozzo RV, Smith A, Dolan MC, et al. (2001). Resistance to Lyme disease in decorin-deficient mice. The Journal of Clinical Investigation, 107, 845–852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Caimano MJ, Eggers CH, Hazlett KR, & Radolf JD (2004). RpoS is not central to the general stress response in Borrelia burgdorferi but does control expression of one or more essential virulence determinants. Infection and Immunity, 72, 6433–6445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Caine JA, & Coburn J (2016). Multifunctional and redundant roles of Borrelia burgdorferi outer surface proteins in tissue adhesion, colonization, and complement evasion. Frontiers in Immunology, 7, 442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Caine JA, Lin YP, Kessler JR, Sato H, Leong JM, & Coburn J (2017). Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival. Cellular Microbiology, 19, e12786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Charon NW, Cockburn A, Li C, Liu J, Miller KA, Miller MR, … Wolgemuth CW (2012). The unique paradigm of spirochete motility and chemotaxis. Annual Review of Microbiology, 66, 349–370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Charon NW, & Goldstein SF (2002). Genetics of motility and chemotaxis of a fascinating group of bacteria: The spirochetes. Annual Review of Genetics, 36, 47–73. [DOI] [PubMed] [Google Scholar]
- Coburn J, Fischer JR, & Leong JM (2005). Solving a sticky problem: new genetic approaches to host cell adhesion by the Lyme disease spirochete. Molecular Microbiology, 57, 1182–1195. [DOI] [PubMed] [Google Scholar]
- Coburn J, Leong J, & Chaconas G (2013). Illuminating the roles of the Borrelia burgdorferi adhesins. Trends in Microbiology, 21, 372–379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coleman JL, Roemer EJ, & Benach JL (1999). Plasmin-coated Borrelia burgdorferi degrades soluble and insoluble components of the mammalian extracellular matrix. Infection and Immunity, 67, 3929–3936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Silva AM, & Fikrig E (1997). Arthropod- and host-specific gene expression by Borrelia burgdorferi. The Journal of Clinical Investigation, 99, 377–379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Silva AM, Tyson KR, & Pal U (2009). Molecular characterization of the tick-Borrelia interface. Frontiers in Bioscience, 14, 3051–3063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Taeye SW, Kreuk L, van Dam AP, Hovius JW, & Schuijt TJ (2013). Complement evasion by Borrelia burgdorferi: It takes three to tango. Trends in Parasitology, 29, 119–128. [DOI] [PubMed] [Google Scholar]
- Djordjevic S, & Stock AM (1998). Structural analysis of bacterial chemotaxis proteins: Components of a dynamic signaling system. Journal of Structural Biology, 124, 189–200. [DOI] [PubMed] [Google Scholar]
- Floden AM, Watt JA, & Brissette CA (2011). Borrelia burgdorferi enolase is a surface-exposed plasminogen binding protein. PLoS one, 6, e27502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuchs H, Wallich R, Simon MM, & Kramer MD (1994). The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin (ogen) receptor. Proc. Natl. Acad. Sci. (U. S. A.), 91, 12594–12598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garcia BL, Zhi H, Wager B, Hook M, & Skare JT (2016). Borrelia burgdorferi BBK32 inhibits the classical pathway by blocking activation of the C1 complement complex. PLoS Pathogens, 12, e1005404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaultney RA, Gonzalez T, Floden AM, & Brissette CA (2013). BB0347, from the lyme disease spirochete Borrelia burgdorferi, is surface exposed and interacts with the CS1 heparin-binding domain of human fibronectin. PLoS one, 8, e75643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gebbia JA, Coleman JL, & Benach JL (2004). Selective induction of matrix metalloproteinases by Borrelia burgdorferi via toll-like receptor 2 in monocytes. The Journal of Infectious Diseases, 189, 113–119. [DOI] [PubMed] [Google Scholar]
- Goldstein SF, Li C, Liu J, Miller M, Motaleb MA, Norris SJ, et al. (2010). The chic motility and chemotaxis of Borrelia burgdorferi. In Samuels DS, & Radolf JD (Eds.), Borrelia, molecular biology, host interaction and pathogenesis (pp. 161–181). Norfolk, UK: Caister Academic Press. [Google Scholar]
- Groshong AM, Fortune DE, Moore BP, Spencer HJ, Skinner RA, Bellamy WT, & Blevins JS (2014). BB0238, a presumed tetratricopeptide repeat-containing protein, is required during Borrelia burgdorferi mammalian infection. Infection and Immunity, 82, 4292–4306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guo BP, Brown EL, Dorward DW, Rosenberg LC, & Hook M (1998). Decorin-binding adhesins from Borrelia burgdorferi. Molecular Microbiology, 30, 711–723. [DOI] [PubMed] [Google Scholar]
- Hallstrom T, Haupt K, Kraiczy P, Hortschansky P, Wallich R, Skerka C, & Zipfel PF (2010). Complement regulator-acquiring surface protein 1 of Borrelia burgdorferi binds to human bone morphogenic protein 2, several extracellular matrix proteins, and plasminogen. The Journal of Infectious Diseases, 202, 490–498. [DOI] [PubMed] [Google Scholar]
- Hyde JA, Weening EH, Chang M, Trzeciakowski JP, Hook M, Cirillo JD, & Skare JT (2011). Bioluminescent imaging of Borrelia burgdorferi in vivo demonstrates that the fibronectin-binding protein BBK32 is required for optimal infectivity. Molecular Microbiology, 82, 99–113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Iqbal H, Kenedy MR, Lybecker M, & Akins DR (2016). The TamB ortholog of Borrelia burgdorferi interacts with the beta-barrel assembly machine (BAM) complex protein BamA. Molecular Microbiology, 102, 757–774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kariu T, Sharma K, Singh P, Smith AA, Backstedt B, Buyuktanir O, & Pal U (2015). BB0323 and novel virulence determinant BB0238: Borrelia burgdorferi proteins that interact with and stabilize each other and are critical for infectivity. The Journal of Infectious Diseases, 211, 462–471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kariu T, Yang X, Marks CB, Zhang X, & Pal U (2013). Proteolysis of BB0323 results in two polypeptides that impact physiologic and infectious phenotypes in Borrelia burgdorferi. Molecular Microbiology, 88, 510–522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kenedy MR, Lenhart TR, & Akins DR (2012). The role of Borrelia burgdorferi outer surface proteins. FEMS Immunology and Medical Microbiology, 66, 1–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khan SH, Ahmad F, Ahmad N, Flynn DC, & Kumar R (2011). Protein-protein interactions: Principles, techniques, and their potential role in new drug development. Journal of Biomolecular Structure & Dynamics, 28, 929–938. [DOI] [PubMed] [Google Scholar]
- Koenigs A, Hammerschmidt C, Jutras BL, Pogoryelov D, Barthel D, Skerka C, … Kraiczy P (2013). BBA70 of Borrelia burgdorferi is a novel plasminogen-binding protein. The Journal of Biological Chemistry, 288, 25229–25243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kraiczy P (2016). Hide and seek: How Lyme disease spirochetes overcome complement attack. Frontiers in Immunology, 7, 385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kung F, Anguita J, & Pal U (2013). Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector. Future Microbiology, 8, 41–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kung F, Kaur S, Smith AA, Yang X, Wilder CN, Sharma K, … Pal U (2016). A Borrelia burgdorferi surface-exposed transmembrane protein lacking detectable immune responses supports pathogen persistence and constitutes a vaccine target. The Journal of Infectious Diseases, 213, 1786–1795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lagal V, Portnoi D, Faure G, Postic D, & Baranton G (2006). Borrelia burgdorferi sensu stricto invasiveness is correlated with OspC-plasminogen affinity. Microbes and Infection, 8, 645–652. [DOI] [PubMed] [Google Scholar]
- Lenhart TR, & Akins DR (2009). Borrelia burgdorferi locus BB0795 encodes a BamA orthologue required for growth and efficient localization of outer membrane proteins. Molecular Microbiology, 75, 692–709. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lenhart TR, Kenedy MR, Yang X, Pal U, & Akins DR (2012). BB0324 and BB0028 are constituents of the Borrelia burgdorferi beta-barrel assembly machine (BAM) complex. BMC Microbiology, 12, 60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li C, Motaleb A, Sal M, Goldstein SF, & Charon NW (2000). Spirochete periplasmic flagella and motility. Journal of Molecular Microbiology and Biotechnology, 2, 345–354. [PubMed] [Google Scholar]
- Lin Y, Li Y, Zhu Y, Zhang J, Li Y, Liu X, … Si S (2012). Identification of antituberculosis agents that target ribosomal protein interactions using a yeast two-hybrid system. Proceedings of the National Academy of Sciences of the United States of America, 109, 17412–17417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin YP, Benoit V, Yang X, Martinez-Herranz R, Pal U, & Leong JM (2014). Strain-specific variation of the decorin-binding adhesin DbpA influences the tissue tropism of the lyme disease spirochete. PLoS Pathogens, 10, e1004238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mead PS (2015). Epidemiology of Lyme disease. Infectious Disease Clinics of North America, 29, 187–210. [DOI] [PubMed] [Google Scholar]
- Moon KH, Hobbs G, & Motaleb MA (2016). Borrelia burgdorferi CheD promotes various functions in chemotaxis and the pathogenic life cycle of the spirochete. Infection and Immunity, 84, 1743–1752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Motaleb MA, Liu J, & Wooten RM (2015). Spirochetal motility and chemotaxis in the natural enzootic cycle and development of Lyme disease. Current Opinion in Microbiology, 28, 106–113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Motaleb MA, Miller MR, Bakker RG, Li C, & Charon NW (2007). Isolation and characterization of chemotaxis mutants of the Lyme disease Spirochete Borrelia burgdorferi using allelic exchange mutagenesis, flow cytometry, and cell tracking. Methods in Enzymology, 422, 421–437. [DOI] [PubMed] [Google Scholar]
- Nogueira SV, Smith AA, Qin JH, & Pal U (2012). A surface enolase participates in Borrelia burgdorferi-plasminogen interaction and contributes to pathogen survival within feeding ticks. Infection and Immunity, 80, 82–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Norris SJ (2006). The dynamic proteome of Lyme disease Borrelia. Genome Biology, 7, 209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Norris SJ (2014). The vls antigenic variation systems of Lyme disease Borrelia: Eluding host immunity through both random, segmental gene conversion and framework heterogeneity. Microbiol Spectr, 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Novak EA, Sekar P, Xu H, Moon KH, Manne A, Wooten RM, & Motaleb MA (2016). The Borrelia burgdorferi CheY3 response regulator is essential for chemotaxis and completion of its natural infection cycle. Cellular Microbiology, 18, 1782–1799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Onder O, Humphrey PT, McOmber B, Korobova F, Francella N, Greenbaum DC, & Brisson D (2012). OspC is potent plasminogen receptor on surface of Borrelia burgdorferi. The Journal of Biological Chemistry, 287, 16860–16868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ostberg Y, Carroll JA, Pinne M, Krum JG, Rosa P, & Bergstrom S (2004). Pleiotropic effects of inactivating a carboxyl-terminal protease, CtpA, in Borrelia burgdorferi. Journal of Bacteriology, 186, 2074–2084. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pal U, & Fikrig E (2003). Adaptation of Borrelia burgdorferi in the vector and vertebrate host. Microbes and Infection, 5, 659–666. [DOI] [PubMed] [Google Scholar]
- Pal U, & Fikrig E (2010). Tick interactions. In Samuels DS, & Radolf JD (Eds.), Borrelia, molecular biology, host interaction and pathogenesis (pp. 279–298). Norfolk, UK: Caister Academic Press. [Google Scholar]
- Radolf JD, Caimano MJ, Stevenson B, & Hu LT (2012). Of ticks, mice and men: Understanding the dual-host lifestyle of Lyme disease spirochaetes. Nature Reviews. Microbiology, 10, 87–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ramamoorthi N, Narasimhan S, Pal U, Bao F, Yang XF, Fish D, … Fikrig E (2005). The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature, 436, 573–577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ristow LC, Bonde M, Lin YP, Sato H, Curtis M, Wesley E, … Coburn J (2015). Integrin binding by Borrelia burgdorferi P66 facilitates dissemination but is not required for infectivity. Cellular Microbiology, 17, 1021–1036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ristow LC, Miller HE, Padmore LJ, Chettri R, Salzman N, Caimano MJ, et al. (2012). The beta(3)-integrin ligand of Borrelia burgdorferi is critical for infection of mice but not ticks. Mol Microbiol. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rogovskyy AS, Casselli T, Tourand Y, Jones CR, Owen JP, Mason KL, … Bankhead T (2015). Evaluation of the importance of VlsE antigenic variation for the enzootic cycle of Borrelia burgdorferi. PLoS one, 10, e0124268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosa PA, Tilly K, & Stewart PE (2005). The burgeoning molecular genetics of the Lyme disease spirochaete. Nature Reviews. Microbiology, 3, 129–143. [DOI] [PubMed] [Google Scholar]
- Russell TM, & Johnson BJ (2013). Lyme disease spirochaetes possess an aggrecan-binding protease with aggrecanase activity. Molecular Microbiology, 90, 228–240. [DOI] [PubMed] [Google Scholar]
- Sal MS, Li C, Motalab MA, Shibata S, Aizawa S, & Charon NW (2008). Borrelia burgdorferi uniquely regulates its motility genes and has an intricate flagellar hook-basal body structure. Journal of Bacteriology, 190, 1912–1921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schramm F, Kern A, Barthel C, Nadaud S, Meyer N, Jaulhac B, & Boulanger N (2012). Microarray analyses of inflammation response of human dermal fibroblasts to different strains of Borrelia burgdorferi sensu stricto. PLoS one, 7, e40046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shi Y, Xu Q, McShan K, & Liang FT (2008). Both decorin-binding proteins A and B are critical for the overall virulence of Borrelia burgdorferi. Infection and Immunity, 76, 1239–1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steere AC, Coburn J, & Glickstein L (2004). The emergence of Lyme disease. The Journal of Clinical Investigation, 113, 1093–1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stewart PE, Hoff J, Fischer E, Krum JG, & Rosa PA (2004). Genome-wide transposon mutagenesis of Borrelia burgdorferi for identification of phenotypic mutants. Applied and Environmental Microbiology, 70, 5973–5979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sze CW, Zhang K, Kariu T, Pal U, & Li C (2012). Borrelia burgdorferi needs chemotaxis to establish infection in mammals and to accomplish its enzootic cycle. Infection and Immunity, 80, 2485–2492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thakur M, Sharma K, Chao K, Smith AA, Herzberg O, & Pal U (2017). A protein-protein interaction dictates borrelial infectivity. Scientific Reports, 7, 2932. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Toledo A, Coleman JL, Kuhlow CJ, Crowley JT, & Benach JL (2011). The enolase of Borrelia burgdorferi is a plasminogen receptor released in outer membrane vesicles. Infection and Immunity, 80, 359–368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Verma A, Brissette CA, Bowman A, & Stevenson B (2009). Borrelia burgdorferi BmpA is a laminin-binding protein. Infection and Immunity, 77, 4940–4946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weening EH, Parveen N, Trzeciakowski JP, Leong JM, Hook M, & Skare JT (2008). Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection. Infection and Immunity, 76, 5694–5705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wood E, Tamborero S, Mingarro I, & Esteve-Gassent MD (2013). BB0172, a Borrelia burgdorferi outer membrane Protein that binds integrin alpha3beta1. Journal of Bacteriology, 195, 3320–3330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang X, Coleman AS, Anguita J, & Pal U (2009). A chromosomally encoded virulence factor protects the Lyme disease pathogen against host-adaptive immunity. PLoS Pathogens, 5, e1000326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang X, Lenhart TR, Kariu T, Anguita J, Akins DR, & Pal U (2010). Characterization of unique regions of Borrelia burgdorferi surface-located membrane protein 1. Infection and Immunity, 78, 4477–4487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang X, Lin YP, Heselpoth RD, Buyuktanir O, Qin J, Kung F, … Pal U (2016). Middle region of the Borrelia burgdorferi surface-located protein 1 (Lmp1) interacts with host chondroitin-6-sulfate and independently facilitates infection. Cellular Microbiology, 18, 97–110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang X, Promnares K, Qin J, He M, Shroder DY, Kariu T, … Pal U (2011). Characterization of multiprotein complexes of the Borrelia burgdorferi outer membrane vesicles. Journal of Proteome Research, 10, 4556–4566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang X, Thakur M, Koci J, Smith AA, Singh P, Zhuang X, … Pal U (2018). Analysis of Borrelia burgdorferi proteome and protein-protein interactions. Methods in Molecular Biology, 1690, 259–277. [DOI] [PubMed] [Google Scholar]
- Ye M, Sharma K, Thakur M, Smith AA, Buyuktanir O, Xiang X, … Pal U (2016). HtrA, a temperature- and stationary phase-activated protease involved in maturation of a key microbial virulence determinant, facilitates Borrelia burgdorferi infection in mammalian hosts. Infection and Immunity, 84, 2372–2381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang JR, Hardham JM, Barbour AG, & Norris SJ (1997). Antigenic variation in Lyme disease Borreliae by promiscuous recombination of Vmp-like sequence cassettes. Cell, 89, 275–285. [DOI] [PubMed] [Google Scholar]
- Zhang X, Yang X, Kumar M, & Pal U (2009). BB0323 function is essential for Borrelia burgdorferi virulence and persistence through tick-rodent transmission cycle. The Journal of Infectious Diseases, 200, 1318–1330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhi H, Weening EH, Barbu EM, Hyde JA, Hook M, & Skare JT (2015). The BBA33 lipoprotein binds collagen and impacts Borrelia burgdorferi pathogenesis. Molecular Microbiology, 96, 68–83. [DOI] [PMC free article] [PubMed] [Google Scholar]